| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.37 | 0.008 |